International Medical Center of Biomaterials Processing and Cryostorage (MOEX: GEMA)
Russia
· Delayed Price · Currency is RUB 672.00
-1.50 (-0.22%)
At close: Jul 8, 2022
GEMA Cash Flow Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2015 |
| Net Income | - | 98.17 | 129.17 | 122.77 | 119.26 | 141.76 | Upgrade
|
| Depreciation & Amortization | - | 6.86 | 4.15 | 10.41 | 5.32 | 6.33 | Upgrade
|
| Other Operating Activities | - | 136.07 | 111.19 | 4.69 | -0.54 | -4.32 | Upgrade
|
| Change in Accounts Receivable | - | - | - | -11.99 | -41.52 | 59.21 | Upgrade
|
| Change in Inventory | - | - | - | -1.07 | -1.04 | 2.26 | Upgrade
|
| Change in Accounts Payable | - | - | - | 19.2 | 31.67 | -42.17 | Upgrade
|
| Operating Cash Flow | - | 241.11 | 244.51 | 134.72 | 113.14 | 163.07 | Upgrade
|
| Operating Cash Flow Growth | - | -1.39% | 81.50% | 19.07% | -30.62% | 48.07% | Upgrade
|
| Capital Expenditures | - | -9.27 | -4.68 | -2.46 | - | - | Upgrade
|
| Investment in Securities | - | -99 | -506.4 | - | - | - | Upgrade
|
| Other Investing Activities | - | 0.89 | 32.19 | 1.17 | 0.43 | 5.87 | Upgrade
|
| Investing Cash Flow | - | -252.87 | -77.52 | -54.92 | -176.36 | -5.46 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 29.99 | - | Upgrade
|
| Long-Term Debt Issued | - | 200 | - | - | - | 8 | Upgrade
|
| Total Debt Issued | - | 200 | - | - | 29.99 | 8 | Upgrade
|
| Long-Term Debt Repaid | - | -1.87 | - | - | - | -8.4 | Upgrade
|
| Net Debt Issued (Repaid) | - | 198.13 | - | - | 29.99 | -0.4 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 150.39 | - | Upgrade
|
| Common Dividends Paid | - | -141.06 | -150.19 | -85.1 | -83.47 | -150.85 | Upgrade
|
| Other Financing Activities | - | -5 | -6.02 | -4.04 | -4.68 | -1.31 | Upgrade
|
| Financing Cash Flow | - | 52.07 | -156.21 | -89.14 | 92.23 | -152.56 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.3 | -0.01 | -0.09 | - | -0.03 | Upgrade
|
| Net Cash Flow | - | 40.01 | 10.76 | -9.43 | 29.01 | 5.02 | Upgrade
|
| Free Cash Flow | - | 231.83 | 239.82 | 132.26 | 113.14 | 163.07 | Upgrade
|
| Free Cash Flow Growth | - | -3.33% | 81.33% | 16.90% | -30.62% | 48.37% | Upgrade
|
| Free Cash Flow Margin | - | 91.03% | 90.20% | 54.51% | 47.42% | 67.21% | Upgrade
|
| Free Cash Flow Per Share | - | 15.53 | 16.06 | 8.86 | 8.42 | 12.85 | Upgrade
|
| Cash Interest Paid | - | 3.74 | 3.52 | 4.04 | 4.68 | 1.31 | Upgrade
|
| Levered Free Cash Flow | - | 557.61 | -334.44 | 95.29 | 91.87 | 120.85 | Upgrade
|
| Unlevered Free Cash Flow | - | 568.62 | -332.25 | 99.57 | 94.8 | 121.67 | Upgrade
|
| Change in Net Working Capital | 42.32 | -484.58 | 417.89 | -2.96 | -3.59 | -18.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.